Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Blood|June 26, 2004
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX geneDenise E Sabatino, Elina Armstrong, Shyrie Edmonson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 7, 2008
Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemiaSapna Gupta, Jirko Kühnisch, Aladdin Mustafa, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Ultrasound in Medicine & Biology|October 29, 2011
ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophiliaMallory R Scola, Timothy C Nichols, Hongtu Zhu, et al.
Human Gene Therapy|March 7, 2013
Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humansElizabeth M Parzych, Hua Li, Xiangfan Yin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2013
Enhanced T cell function in a mouse model of human glycosylationGeorge Buchlis, Pamela Odorizzi, Paula C Soto, et al.
ILAR Journal|March 19, 2009
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiencyTimothy C Nichols, Aaron M Dillow, Helen W G Franck, et al.
Blood|December 26, 2008
Successful treatment of canine hemophilia by continuous expression of canine FVIIaParis Margaritis, Elise Roy, Majed N Aljamali, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2007
A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticinChunmei Yang, Jinong Feng, Wenjia Song, et al.
Blood|October 30, 2008
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapyGlenn P Niemeyer, Roland W Herzog, Jane Mount, et al.
Pageof 15